MONOPHARMA — Mono Pharmacare Balance Sheet
0.000.00%
- IN₹386.06m
- IN₹915.04m
- IN₹1.68bn
- 30
- 84
- 21
- 40
Annual balance sheet for Mono Pharmacare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.73 | 2.45 | 7.99 | 3.63 | 6.98 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 64.7 | 91 | 389 | 363 | 520 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 108 | 141 | 793 | 802 | 1,090 |
Net Property, Plant And Equipment | 3.91 | 2.97 | 11.3 | 8.99 | 10 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 112 | 144 | 811 | 811 | 1,101 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 65.4 | 85.9 | 461 | 358 | 528 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 75.3 | 101 | 631 | 530 | 789 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 37 | 42.8 | 180 | 281 | 312 |
Total Liabilities & Shareholders' Equity | 112 | 144 | 811 | 811 | 1,101 |
Total Common Shares Outstanding |